Immunoanalysis data revealed that at 7 days of differentiation, TAFH RNAi-treated melanomas showed high levels of expression of chondrocyte-specific SOX9 proteins (Fig. 3c) and prominent staining with Alcian blue that evidenced the synthesis of cartilage-specific ECM-proteins (Fig. 3d). The gene discussed is SOX9; the disease is melanoma.